A case of Müllerian adenosarcoma of the uterus treated with liposomal doxorubicin

Gynecologic Oncology

Volumn 88, Issue 3, 2003, Pages 456-458

  Del Carmen, Marcela G ^a,c   Lovett, David ^b   Goodman, Annekathryn ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CAPE COD HOSPITAL   (United States)

^c Kelly Gynecologic Oncology Service   (United States)

Author keywords

Chemotherapy; Liposomal doxorubicin; Recurrent; Uterine adenocarcinoma

Indexed keywords

CARBOPLATIN; DOXORUBICIN; IFOSFAMIDE; MEGESTROL ACETATE; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DEHYDRATION; DISEASE COURSE; DRUG FORMULATION; DRUG WITHDRAWAL; ENDOMETRIUM SARCOMA; FAILURE TO THRIVE; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; LETHARGY; MUELLERIAN ADENOSARCOMA; PELVIS CANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TERMINAL CARE; VAGINA CARCINOMA;

EID: 0037343175     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00093-8     Document Type: Article

References (10)

1. Clement P.B. Müllerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol. 13:1989;28-38.
2. Clement P.B., Scully R.E. Müllerian adenosarcoma of the uterus a clinicopathologic analysis of 100 cases with a review of the literature . Hum Pathol. 21:1990;363-368.
3. Andrade L.A., Derchain S.F.M., Vial J.S., Alvarenga M. Müllerian adenosarcoma of the uterus in adolescents. Int J Gynecol Obstet. 38:1992;119-123.
4. Kaku T., Silverberg S.G., Major F.J. Adenosarcoma of the uterus a Gynecologic Oncology Group clinicopathologic study of 31 cases . Int J Gynecol Pathol. 11:1992;75-79.
5. Andrade L.A., Derchain S.F.M., Vial J.S., Alvarenga M. Müllerian adenosarcoma of the uterus in adolescents. Int J Gynecol Obstet. 38:1992;119-123.
6. Zaloudek C., Maj M.C., Norris J. Adenofibroma and adenosarcoma of the uterus a clinicopathologic study of 35 cases . Cancer. 48:1981;354-366.
7. Thigpen J.T., Blessing J.A., Beecham J. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas a gynecologic oncology group study . J Clin Oncol. 9:1991;1962-1967.
8. Omura G.A., Major F.J., Blessing J.A. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 52:1983;626-629.
9. Sutton G., Blessing J.A., Rosenshein N. Phase II trial of Ifosfamide and mesna in mixed mesodermal tumors of the uterus (a gynecologic oncology group study). Am J Obstet Gynecol. 166:1989;309-312.
10. Verschraegen C.F., Vasuratna A., Edwards C., Freedman R., Kudelka A.P., Tornos C., Kavanagh J.T. Clinicopathologic analysis of Müllerian adenosarcoma the MD Anderson Cancer Center experience . Oncol Rep. 5:1998;939-944.